 | • レポートコード：MRC2-11QY05520 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエダラボンのグローバル市場について調査・分析したレポートです。種類別（経口、注射）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エダラボンの競争状況、市場シェア ・世界のエダラボン市場：種類別市場規模 2015年-2020年（経口、注射） ・世界のエダラボン市場：種類別市場規模予測 2021年-2026年（経口、注射） ・世界のエダラボン市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のエダラボン市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のエダラボン市場分析：米国、カナダ ・ヨーロッパのエダラボン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエダラボン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエダラボン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエダラボン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Mitsubishi Tanabe Pharma、Simcere、Taj Pharmaceuticals Ltd.、Sun Pharmaceutical Industries Ltd.、Unichem Laboratories Ltd、UCB India Ltd、Piramal Healthcare ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Edaravone Market
The global Edaravone market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Edaravone Scope and Market Size
Edaravone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Edaravone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Edaravone market is segmented into
Oral
Injection
Segment by Application, the Edaravone market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Edaravone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Edaravone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Edaravone Market Share Analysis
Edaravone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Edaravone business, the date to enter into the Edaravone market, Edaravone product introduction, recent developments, etc.
The major vendors covered:
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
…
1 Study Coverage
1.1 Edaravone Product Introduction
1.2 Market Segments
1.3 Key Edaravone Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Edaravone Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Edaravone Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Edaravone Market Size, Estimates and Forecasts
2.1.1 Global Edaravone Revenue 2015-2026
2.1.2 Global Edaravone Sales 2015-2026
2.2 Global Edaravone, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Edaravone Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Edaravone Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Edaravone Competitor Landscape by Players
3.1 Edaravone Sales by Manufacturers
3.1.1 Edaravone Sales by Manufacturers (2015-2020)
3.1.2 Edaravone Sales Market Share by Manufacturers (2015-2020)
3.2 Edaravone Revenue by Manufacturers
3.2.1 Edaravone Revenue by Manufacturers (2015-2020)
3.2.2 Edaravone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Edaravone Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Edaravone Revenue in 2019
3.2.5 Global Edaravone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Edaravone Price by Manufacturers
3.4 Edaravone Manufacturing Base Distribution, Product Types
3.4.1 Edaravone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Edaravone Product Type
3.4.3 Date of International Manufacturers Enter into Edaravone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Edaravone Market Size by Type (2015-2020)
4.1.1 Global Edaravone Sales by Type (2015-2020)
4.1.2 Global Edaravone Revenue by Type (2015-2020)
4.1.3 Edaravone Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Edaravone Market Size Forecast by Type (2021-2026)
4.2.1 Global Edaravone Sales Forecast by Type (2021-2026)
4.2.2 Global Edaravone Revenue Forecast by Type (2021-2026)
4.2.3 Edaravone Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Edaravone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Edaravone Market Size by Application (2015-2020)
5.1.1 Global Edaravone Sales by Application (2015-2020)
5.1.2 Global Edaravone Revenue by Application (2015-2020)
5.1.3 Edaravone Price by Application (2015-2020)
5.2 Edaravone Market Size Forecast by Application (2021-2026)
5.2.1 Global Edaravone Sales Forecast by Application (2021-2026)
5.2.2 Global Edaravone Revenue Forecast by Application (2021-2026)
5.2.3 Global Edaravone Price Forecast by Application (2021-2026)
6 North America
6.1 North America Edaravone by Country
6.1.1 North America Edaravone Sales by Country
6.1.2 North America Edaravone Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Edaravone Market Facts & Figures by Type
6.3 North America Edaravone Market Facts & Figures by Application
7 Europe
7.1 Europe Edaravone by Country
7.1.1 Europe Edaravone Sales by Country
7.1.2 Europe Edaravone Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Edaravone Market Facts & Figures by Type
7.3 Europe Edaravone Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Edaravone by Region
8.1.1 Asia Pacific Edaravone Sales by Region
8.1.2 Asia Pacific Edaravone Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Edaravone Market Facts & Figures by Type
8.3 Asia Pacific Edaravone Market Facts & Figures by Application
9 Latin America
9.1 Latin America Edaravone by Country
9.1.1 Latin America Edaravone Sales by Country
9.1.2 Latin America Edaravone Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Edaravone Market Facts & Figures by Type
9.3 Central & South America Edaravone Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Edaravone by Country
10.1.1 Middle East and Africa Edaravone Sales by Country
10.1.2 Middle East and Africa Edaravone Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Edaravone Market Facts & Figures by Type
10.3 Middle East and Africa Edaravone Market Facts & Figures by Application
11 Company Profiles
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mitsubishi Tanabe Pharma Edaravone Products Offered
11.1.5 Mitsubishi Tanabe Pharma Related Developments
11.2 Simcere
11.2.1 Simcere Corporation Information
11.2.2 Simcere Description and Business Overview
11.2.3 Simcere Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Simcere Edaravone Products Offered
11.2.5 Simcere Related Developments
11.3 Taj Pharmaceuticals Ltd.
11.3.1 Taj Pharmaceuticals Ltd. Corporation Information
11.3.2 Taj Pharmaceuticals Ltd. Description and Business Overview
11.3.3 Taj Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Taj Pharmaceuticals Ltd. Edaravone Products Offered
11.3.5 Taj Pharmaceuticals Ltd. Related Developments
11.4 Sun Pharmaceutical Industries Ltd.
11.4.1 Sun Pharmaceutical Industries Ltd. Corporation Information
11.4.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
11.4.3 Sun Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Products Offered
11.4.5 Sun Pharmaceutical Industries Ltd. Related Developments
11.5 Unichem Laboratories Ltd
11.5.1 Unichem Laboratories Ltd Corporation Information
11.5.2 Unichem Laboratories Ltd Description and Business Overview
11.5.3 Unichem Laboratories Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Unichem Laboratories Ltd Edaravone Products Offered
11.5.5 Unichem Laboratories Ltd Related Developments
11.6 UCB India Ltd
11.6.1 UCB India Ltd Corporation Information
11.6.2 UCB India Ltd Description and Business Overview
11.6.3 UCB India Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 UCB India Ltd Edaravone Products Offered
11.6.5 UCB India Ltd Related Developments
11.7 Piramal Healthcare
11.7.1 Piramal Healthcare Corporation Information
11.7.2 Piramal Healthcare Description and Business Overview
11.7.3 Piramal Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Piramal Healthcare Edaravone Products Offered
11.7.5 Piramal Healthcare Related Developments
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mitsubishi Tanabe Pharma Edaravone Products Offered
11.1.5 Mitsubishi Tanabe Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Edaravone Market Estimates and Projections by Region
12.1.1 Global Edaravone Sales Forecast by Regions 2021-2026
12.1.2 Global Edaravone Revenue Forecast by Regions 2021-2026
12.2 North America Edaravone Market Size Forecast (2021-2026)
12.2.1 North America: Edaravone Sales Forecast (2021-2026)
12.2.2 North America: Edaravone Revenue Forecast (2021-2026)
12.2.3 North America: Edaravone Market Size Forecast by Country (2021-2026)
12.3 Europe Edaravone Market Size Forecast (2021-2026)
12.3.1 Europe: Edaravone Sales Forecast (2021-2026)
12.3.2 Europe: Edaravone Revenue Forecast (2021-2026)
12.3.3 Europe: Edaravone Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Edaravone Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Edaravone Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Edaravone Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Edaravone Market Size Forecast by Region (2021-2026)
12.5 Latin America Edaravone Market Size Forecast (2021-2026)
12.5.1 Latin America: Edaravone Sales Forecast (2021-2026)
12.5.2 Latin America: Edaravone Revenue Forecast (2021-2026)
12.5.3 Latin America: Edaravone Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Edaravone Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Edaravone Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Edaravone Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Edaravone Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Edaravone Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Edaravone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Edaravone Market Segments
Table 2. Ranking of Global Top Edaravone Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Edaravone Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Edaravone Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Edaravone Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Edaravone Sales by Regions 2015-2020 (K Units)
Table 9. Global Edaravone Sales Market Share by Regions (2015-2020)
Table 10. Global Edaravone Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Edaravone Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Edaravone Sales Share by Manufacturers (2015-2020)
Table 13. Global Edaravone Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Edaravone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Edaravone as of 2019)
Table 15. Edaravone Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Edaravone Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Edaravone Price (2015-2020) (USD/Unit)
Table 18. Edaravone Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Edaravone Product Type
Table 20. Date of International Manufacturers Enter into Edaravone Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Edaravone Sales by Type (2015-2020) (K Units)
Table 23. Global Edaravone Sales Share by Type (2015-2020)
Table 24. Global Edaravone Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Edaravone Revenue Share by Type (2015-2020)
Table 26. Edaravone Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Edaravone Sales by Application (2015-2020) (K Units)
Table 28. Global Edaravone Sales Share by Application (2015-2020)
Table 29. North America Edaravone Sales by Country (2015-2020) (K Units)
Table 30. North America Edaravone Sales Market Share by Country (2015-2020)
Table 31. North America Edaravone Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Edaravone Revenue Market Share by Country (2015-2020)
Table 33. North America Edaravone Sales by Type (2015-2020) (K Units)
Table 34. North America Edaravone Sales Market Share by Type (2015-2020)
Table 35. North America Edaravone Sales by Application (2015-2020) (K Units)
Table 36. North America Edaravone Sales Market Share by Application (2015-2020)
Table 37. Europe Edaravone Sales by Country (2015-2020) (K Units)
Table 38. Europe Edaravone Sales Market Share by Country (2015-2020)
Table 39. Europe Edaravone Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Edaravone Revenue Market Share by Country (2015-2020)
Table 41. Europe Edaravone Sales by Type (2015-2020) (K Units)
Table 42. Europe Edaravone Sales Market Share by Type (2015-2020)
Table 43. Europe Edaravone Sales by Application (2015-2020) (K Units)
Table 44. Europe Edaravone Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Edaravone Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Edaravone Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Edaravone Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Edaravone Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Edaravone Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Edaravone Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Edaravone Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Edaravone Sales Market Share by Application (2015-2020)
Table 53. Latin America Edaravone Sales by Country (2015-2020) (K Units)
Table 54. Latin America Edaravone Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Edaravone Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Edaravone Revenue Market Share by Country (2015-2020)
Table 57. Latin America Edaravone Sales by Type (2015-2020) (K Units)
Table 58. Latin America Edaravone Sales Market Share by Type (2015-2020)
Table 59. Latin America Edaravone Sales by Application (2015-2020) (K Units)
Table 60. Latin America Edaravone Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Edaravone Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Edaravone Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Edaravone Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Edaravone Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Edaravone Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Edaravone Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Edaravone Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Edaravone Sales Market Share by Application (2015-2020)
Table 69. Mitsubishi Tanabe Pharma Corporation Information
Table 70. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 71. Mitsubishi Tanabe Pharma Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Mitsubishi Tanabe Pharma Product
Table 73. Mitsubishi Tanabe Pharma Recent Development
Table 74. Simcere Corporation Information
Table 75. Simcere Description and Major Businesses
Table 76. Simcere Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Simcere Product
Table 78. Simcere Recent Development
Table 79. Taj Pharmaceuticals Ltd. Corporation Information
Table 80. Taj Pharmaceuticals Ltd. Description and Major Businesses
Table 81. Taj Pharmaceuticals Ltd. Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Taj Pharmaceuticals Ltd. Product
Table 83. Taj Pharmaceuticals Ltd. Recent Development
Table 84. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 85. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 86. Sun Pharmaceutical Industries Ltd. Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sun Pharmaceutical Industries Ltd. Product
Table 88. Sun Pharmaceutical Industries Ltd. Recent Development
Table 89. Unichem Laboratories Ltd Corporation Information
Table 90. Unichem Laboratories Ltd Description and Major Businesses
Table 91. Unichem Laboratories Ltd Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Unichem Laboratories Ltd Product
Table 93. Unichem Laboratories Ltd Recent Development
Table 94. UCB India Ltd Corporation Information
Table 95. UCB India Ltd Description and Major Businesses
Table 96. UCB India Ltd Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. UCB India Ltd Product
Table 98. UCB India Ltd Recent Development
Table 99. Piramal Healthcare Corporation Information
Table 100. Piramal Healthcare Description and Major Businesses
Table 101. Piramal Healthcare Edaravone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Piramal Healthcare Product
Table 103. Piramal Healthcare Recent Development
Table 104. Global Edaravone Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Edaravone Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Edaravone Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Edaravone Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Edaravone Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Edaravone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Edaravone Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Edaravone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Edaravone Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Edaravone Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Edaravone Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Edaravone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Edaravone Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Edaravone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Edaravone Players
Table 122. Edaravone Customers List
Table 123. Edaravone Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Edaravone Product Picture
Figure 2. Global Edaravone Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Edaravone Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Edaravone Report Years Considered
Figure 10. Global Edaravone Market Size 2015-2026 (US$ Million)
Figure 11. Global Edaravone Sales 2015-2026 (K Units)
Figure 12. Global Edaravone Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Edaravone Sales Market Share by Region (2015-2020)
Figure 14. Global Edaravone Sales Market Share by Region in 2019
Figure 15. Global Edaravone Revenue Market Share by Region (2015-2020)
Figure 16. Global Edaravone Revenue Market Share by Region in 2019
Figure 17. Global Edaravone Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Edaravone Revenue in 2019
Figure 19. Edaravone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Edaravone Sales Market Share by Type (2015-2020)
Figure 21. Global Edaravone Sales Market Share by Type in 2019
Figure 22. Global Edaravone Revenue Market Share by Type (2015-2020)
Figure 23. Global Edaravone Revenue Market Share by Type in 2019
Figure 24. Global Edaravone Market Share by Price Range (2015-2020)
Figure 25. Global Edaravone Sales Market Share by Application (2015-2020)
Figure 26. Global Edaravone Sales Market Share by Application in 2019
Figure 27. Global Edaravone Revenue Market Share by Application (2015-2020)
Figure 28. Global Edaravone Revenue Market Share by Application in 2019
Figure 29. North America Edaravone Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Edaravone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Edaravone Sales Market Share by Country in 2019
Figure 32. North America Edaravone Revenue Market Share by Country in 2019
Figure 33. U.S. Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Edaravone Market Share by Type in 2019
Figure 38. North America Edaravone Market Share by Application in 2019
Figure 39. Europe Edaravone Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Edaravone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Edaravone Sales Market Share by Country in 2019
Figure 42. Europe Edaravone Revenue Market Share by Country in 2019
Figure 43. Germany Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Edaravone Market Share by Type in 2019
Figure 54. Europe Edaravone Market Share by Application in 2019
Figure 55. Asia Pacific Edaravone Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Edaravone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Edaravone Sales Market Share by Region in 2019
Figure 58. Asia Pacific Edaravone Revenue Market Share by Region in 2019
Figure 59. China Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Edaravone Market Share by Type in 2019
Figure 82. Asia Pacific Edaravone Market Share by Application in 2019
Figure 83. Latin America Edaravone Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Edaravone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Edaravone Sales Market Share by Country in 2019
Figure 86. Latin America Edaravone Revenue Market Share by Country in 2019
Figure 87. Mexico Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Edaravone Market Share by Type in 2019
Figure 94. Latin America Edaravone Market Share by Application in 2019
Figure 95. Middle East and Africa Edaravone Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Edaravone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Edaravone Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Edaravone Revenue Market Share by Country in 2019
Figure 99. Turkey Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Edaravone Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Edaravone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Edaravone Market Share by Type in 2019
Figure 106. Middle East and Africa Edaravone Market Share by Application in 2019
Figure 107. North America Edaravone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Edaravone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Edaravone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Edaravone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Edaravone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Edaravone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Edaravone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Edaravone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Edaravone Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Edaravone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
筋萎縮性側索硬化症（ALS）治療薬の世界市場（～2026年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…- ボツリヌス毒素注射の世界市場（～2026年） Botulinum toxin is a protein that helps stop muscle spasms when it is injected directly into the muscle. Muscle spasms are caused by chemical messages sent to the muscles from nerves. These messages tell the muscles to contract (to tighten up). Botulinum toxin blocks these messages. Market Analysis …
- プロポフォール中鎖・長鎖脂肪エマルジョン注射の世界市場（～2026年） Market Analysis and Insights: Global Propofol Medium and Long Chain Fat Emulsion Injection Market The global Propofol Medium and Long Chain Fat Emulsion Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Propofo…
- カルシトニン注射の世界市場（～2026年） Market Analysis and Insights: Global Calcitonin Injection Market The global Calcitonin Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcitonin Injection Scope and Market Size Calcitonin Injection market is…
- 粉末射出成形の世界市場（～2026年） Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. The adoption of leading-edge process control and monitoring sys…